膳食补充剂.
- 3-6岁儿童 : 每天1粒,打开胶囊将内容物与食物混合(甜点慕斯,果泥,奶制品甜点……).
- 成人和7岁以上儿童 : 每天1粒,随餐用大杯水吞服.
注意事项
- 膳食补充剂不能替代平衡、多样的饮食以及健康的生活方式.
- 勿超过每日建议用量.
- 请置于儿童不能触及的地方.
- 哺乳期及孕中期妇女可以服用.
- 25摄氏度以下环境储存.
D’Souza, A. L., Rajkumar, C., Cooke, J. & Bulpitt, C. J. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324, 1361 (2002).
Szajewska, H. & Kołodziej, M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 42, 793–801 (2015).
Kotowska, M., Albrecht, P. & Szajewska, H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Alimentary Pharmacology & Therapeutics 21, 583–590 (2005).
Erdeve, O., Tiras, U. & Dallar, Y. The probiotic effect of Saccharomyces boulardii in a pediatric age group. J. Trop. Pediatr. 50, 234–236 (2004).
Shan, L.-S. et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes 4, 329–334 (2013).
McFarland, L. V. et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am. J. Gastroenterol. 90, 439–448 (1995).
Surawicz, C. M. et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96, 981–988 (1989).
Hurduc, V., Plesca, D., Dragomir, D., Sajin, M. & Vandenplas, Y. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta Paediatr. 98, 127–131 (2009).
Szajewska, H., Horvath, A. & Kołodziej, M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 41, 1237–1245 (2015).
McFarland, L. V. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Medicine and Infectious Disease 5, 97–105 (2007).
Kelesidis, T. & Pothoulakis, C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol 5, 111–125 (2012).
Kollaritsch, H., Kremsner, P., Wiedermann, G. & Scheiner, O. Prevention of traveller’s diarrhea: comparison of different non-antibiotic preparations. Travel Med Int 11, 9–17 (1989).
Feizizadeh, S., Salehi-Abargouei, A. & Akbari, V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics 134, e176–191 (2014).
Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K. & Shafaghi, A. Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis. World J. Gastroenterol. 9, 1832–1833 (2003).
Arkolevure®酵母承诺:保证高品质和剂量
啤酒酵母菌是一种非常脆弱的活微生物,其活性受氧气、光照、湿度、高温和时间影响,它的保存方法对于保证质量至关重要.
Arkolevure®啤酒酵母胶囊在受控气氛条件下进行,采用100%不透明和超耐磨铝合金双层超防护泡罩包装,确保了产品在保质期内含酵母剂量超过25亿*。这意味着每粒胶囊可为您带来超过25亿菌落形成单位*的活性酵母.
Arkolevure®以植物胶囊包装,其特殊配方,不添加乳糖,不添加糖和色素,为您提供最佳品质的产品。
成分详情
酵母粉** 啤酒酵母菌 - 菊粉。植物胶囊:羟丙基甲基纤维素.
营养成分表
1粒胶囊 | |
---|---|
啤酒酵母 | (25亿菌落行程单位 *) 250 mg |
菊粉 | 60 mg |
* 正常储存条件下和有效期限内可保证的菌落形成单位(CFU). ** 活性酵母. |
Arkolevure®酵母承诺:保证高品质和剂量
啤酒酵母菌是一种非常脆弱的活微生物,其活性受氧气、光照、湿度、高温和时间影响,它的保存方法对于保证质量至关重要.
Arkolevure®啤酒酵母胶囊在受控气氛条件下进行,采用100%不透明和超耐磨铝合金双层超防护泡罩包装,确保了产品在保质期内含酵母剂量超过25亿*。这意味着每粒胶囊可为您带来超过25亿菌落形成单位*的活性酵母.
Arkolevure®以植物胶囊包装,其特殊配方,不添加乳糖,不添加糖和色素,为您提供最佳品质的产品。
成分详情
酵母粉** 啤酒酵母菌 - 菊粉。植物胶囊:羟丙基甲基纤维素.
营养成分表
1粒胶囊 | |
---|---|
啤酒酵母 | (25亿菌落行程单位 *) 250 mg |
菊粉 | 60 mg |
* 正常储存条件下和有效期限内可保证的菌落形成单位(CFU). ** 活性酵母. |
膳食补充剂.
- 3-6岁儿童 : 每天1粒,打开胶囊将内容物与食物混合(甜点慕斯,果泥,奶制品甜点……).
- 成人和7岁以上儿童 : 每天1粒,随餐用大杯水吞服.
注意事项
- 膳食补充剂不能替代平衡、多样的饮食以及健康的生活方式.
- 勿超过每日建议用量.
- 请置于儿童不能触及的地方.
- 哺乳期及孕中期妇女可以服用.
- 25摄氏度以下环境储存.
D’Souza, A. L., Rajkumar, C., Cooke, J. & Bulpitt, C. J. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324, 1361 (2002).
Szajewska, H. & Kołodziej, M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 42, 793–801 (2015).
Kotowska, M., Albrecht, P. & Szajewska, H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Alimentary Pharmacology & Therapeutics 21, 583–590 (2005).
Erdeve, O., Tiras, U. & Dallar, Y. The probiotic effect of Saccharomyces boulardii in a pediatric age group. J. Trop. Pediatr. 50, 234–236 (2004).
Shan, L.-S. et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes 4, 329–334 (2013).
McFarland, L. V. et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am. J. Gastroenterol. 90, 439–448 (1995).
Surawicz, C. M. et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96, 981–988 (1989).
Hurduc, V., Plesca, D., Dragomir, D., Sajin, M. & Vandenplas, Y. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta Paediatr. 98, 127–131 (2009).
Szajewska, H., Horvath, A. & Kołodziej, M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 41, 1237–1245 (2015).
McFarland, L. V. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Medicine and Infectious Disease 5, 97–105 (2007).
Kelesidis, T. & Pothoulakis, C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol 5, 111–125 (2012).
Kollaritsch, H., Kremsner, P., Wiedermann, G. & Scheiner, O. Prevention of traveller’s diarrhea: comparison of different non-antibiotic preparations. Travel Med Int 11, 9–17 (1989).
Feizizadeh, S., Salehi-Abargouei, A. & Akbari, V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics 134, e176–191 (2014).
Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K. & Shafaghi, A. Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis. World J. Gastroenterol. 9, 1832–1833 (2003).